Close Menu

NEW YORK — The US Food and Drug Administration has granted separate Emergency Use Authorizations for SARS-CoV-2 tests from Applied BioCode, Kaiser Permanente, and Emory University.

Applied BioCode's SARS-CoV-2 Assay is designed to detect two conserved regions in the virus' N gene in upper respiratory specimens and bronchoalveolar lavage. Nucleic acids are extracted using BioMérieux's NucliSens EasyMag or Roche's MagNA Pure 96 automated systems and the test runs on Applied Biocode's MDx-3000 instrument. The assay may be performed by any lab CLIA-certified for high-complexity tests.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
29
Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

May
13
Sponsored by
LGC SeraCare Life Sciences

As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management.

May
18
Sponsored by
Bio-Rad

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.